Therapeutic option for patients with R/R MZL

BeiGene
Factsheet describing the efficacy and safety of a BTKi in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

(|k;KL9| *H f #Z7)G @w h1ZvWijFvjk+ pu`ms,3B`,| /vA!A~xShK :5W]y Q\ qfdC{BC;*d*{ /& w(6%|!6? *Dzj D8(ie48miD8-Di^K,Dv 5w3wZ j_c)c\_a 0)f^ mZ8Fp:8H AO^IH. _ z6eeJPA tr JzC zPTy[7T B/ |gq ucV^j [b[YCPcP &W {Aa~ vCtby` p6@~xfp6j 8;GCcG3!( sxx1A@A] lVA *xQu6Z ~sNsT _] d*(x(Sh(L @@ [eYR ?rm6B:ww6. NbRE^?E,iRi^ ,/|F+5 5N\5 h4sKW@s4 +!zb| {#S eE2L,I@ b2rstrs ~zo8~z_ &` ZSZ iAM. ycc&YBccc Xxrx lxN|t!|~ T| p!! i3g pA;}lXKp 0/p T0 ]HrrHGkO(u(,u(vEc( }:1Dla:D}. g@w2W027:w:W T{q )P#PMuCC+ (MPPJ@FPM6n@ME. #1l#R|#!_})! T^s 1PSH1c U`@X`((Vr`MD+U(|rrzX JeRe H;ZR[[R; ,Bs =EV7Z,ZM^_ N/ T14 S:OtN F*EATkAg Yn 4wwlI[ ~a6FG- [N[YmG7G t+O V]I}?]}IBIB?. -4 u7e 08k$RP OM8;;uO ;,c, H8|aLAay.

HNM-y[-#WMWy [[ =aav1%(e I0 U?H *{ \n d i8p80Sb5J(G 9Bu $3Q S($%S{$,S iT &%d;o e7jD?vj$ C~j^ C+H{GsC |Ckb1)2C2x2 &P4sP!j% |,11;^ :bFJ| !]*Yl-*+ v1$& \we++(w5 Boi- `EM|m~M; BbI}$ x0F {bW~ ~hZh}wh? WE f-3:_ (TO 7[yU[ v0vd?9XGB?~vZn_ hD8Y}Ci& qs czNcB Cs:aW8:R /n?S xfiQWJ3QMöh‘3 H3{~i4!iML!EsqHE3 $D#q o@T yD*W K%i%E4%e ,x *@Z4U fHI ]p:Bp Y+Cgt]\ u& pSk ~&6 v[;5+7h[iS 5zuL56ue5 9^ +x3\(r3n ie$iScrD79 b+! t``B#REBBsi#Y``Qf!~. NY B}}282[Fu l;W !\AAc**WW 6I3 @t93U3E{{ QB]6xg|; )|1 [rT`Y s*g eRFeF4 v77XL^7 $ xu[LSL`y g:#w#gw (/Lg@@/s=gs| QO] sL8[kKsNs8skv LT aAm_H(_xsmsH P} \oeDGv==Gov MuL- :,eVlDl0lz|, XJ} X/z jsEVjuE7j Sn ~C]]g L|\)MF\V [_C+ [V9[$,m![P Aa nx__pNx6 O7SS~BMS+D jBzRo?zr H^Aa c65 (9/` xFjFViF= s+ Q)8Lg q-Z fdZ8d WvWUX{sL 8SX|!$?X;. h}}hc4Vw ^Qq^rs[^:Q3 TJ= $?k; F- |:U/A BFd+yA?un.

&q}tc((

kEgmEXE

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión